Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and apramycin

carbapenems has been researched along with apramycin in 5 studies

Compound Research Comparison

Studies
(carbapenems)		Trials
(carbapenems)		Recent Studies (post-2010)
(carbapenems)		Studies
(apramycin)		Trials
(apramycin)		Recent Studies (post-2010) (apramycin)
7,3551475,277167668

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Aboklaish, AF; Böttger, EC; Cao, S; Crich, D; Ercan, O; Hobbie, SN; Hughes, D; Huseby, DL; Juhas, M; Petersson, A; Polikanov, YS; Rominski, A; Teo, J; Tyrrell, JM; Walsh, TR; Widlake, E1
Becker, K; Gysin, M; Haldimann, K; Hobbie, SN; Plattner, M1
Friberg, LE1
Chen, L; Du, H; Fouts, DE; Hao, M; Kreiswirth, BN; Satlin, M; Schuyler, J; Shashkina, E; Zhang, H1
Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S1

Other Studies

5 other study(ies) available for carbapenems and apramycin

ArticleYear
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
    The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Africa; Aminoglycosides; Anti-Bacterial Agents; Asia; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Genotype; Humans; Microbial Sensitivity Tests; Nebramycin; South America; Whole Genome Sequencing

2019
Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene
    International journal of molecular sciences, 2020, Aug-25, Volume: 21, Issue:17

    Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Catalytic Domain; Databases, Genetic; Drug Resistance, Bacterial; Genome, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methyltransferases; Molecular Epidemiology; Mutagenesis, Site-Directed; Nebramycin; Standard of Care; Structure-Activity Relationship

2020
Pivotal Role of Translation in Anti-Infective Development.
    Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:4

    Topics: Aminoglycosides; Anti-Infective Agents; Antiviral Agents; Carbapenems; Dose-Response Relationship, Drug; Drug Approval; Drug Development; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Models, Biological; Nebramycin; Research Design; United States; United States Food and Drug Administration

2021
Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
    The Journal of antimicrobial chemotherapy, 2021, 07-15, Volume: 76, Issue:8

    Topics: Anti-Bacterial Agents; Carbapenems; Epidemics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Nebramycin

2021
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
    International journal of antimicrobial agents, 2022, Volume: 60, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin

2022